Clinical trial
Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell…
NCT00030849 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00030849 |
|---|---|
| Title | Bexarotene and Interferon Alfa in Treating Patients With Cutaneous T-Cell Lymphoma |
| Official title | Phase II Trial Of Oral Bexarotene (Targretin) Combined With Interferon Alfa-2b (Intron-A) For Patients With Cutaneous T-Cell Lymphoma |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Lymphoma |
| Intervention type | Biological, Drug |
| Interventions | recombinant interferon alfa, bexarotene |
| Start date | Oct 1, 2001 |
| Primary completion | Sep 1, 2004 |
| Completion | Dec 1, 2009 |
| First posted | Jan 27, 2003 |
| Last update posted | Apr 4, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: